En su defecto, se usarn frmulas adaptadas , que constituyen en nuestro medio la nica alternativa adecuada a la leche humana en la alimentacin del RN
7.4.4 Next-generation agonists The development of dual GLP-1/GIP receptor agonists (e.g., tirzepatide) and novel blood-brain barrier-penetrant formulations may offer superior neuroprotective efficacy by more potently engaging central receptors or providing a broader spectrum of action (Ghaleb et al., 2025)
The lesion is benign and may regress following an incisional biopsy [1]
Do you still need exercise while taking a GLP-1
In a head-to-head comparison with exenatide 10 g twice daily, lixisenatide 20 g once daily was non-inferior for HbA 1c reduction, achieved with threefold fewer patients with symptomatic hypoglycemia events and better gastrointestinal tolerability
Why the hype has become so powerful Fitness has always embraced innovation, but todays information landscape has dramatically accelerated the speed with which new trends spread